Sat.Jan 29, 2022 - Fri.Feb 04, 2022

article thumbnail

HHS: Disparities in video telehealth use highlight key barriers to access

Fierce Healthcare

HHS: Disparities in video telehealth use highlight key barriers to access. rking. Wed, 02/02/2022 - 13:45.

144
144
article thumbnail

AI-powered stethoscope from Eko spots heart failure in seconds

pharmaphorum

A study has shown that a ‘smart’ stethoscope developed by US digital health company Eko can be used to screen people for heart failure in a few second during a standard physical examination. The device tested in the independent study combines a stethoscope used to listen to heart sounds with a single-lead electrocardiogram (ECG). It uses an algorithm to detects low left ventricular ejection fraction (LVEF) – reduced outflow of blood from the heart to the aorta – which is a common cha

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI can be a powerful tool in drug development, discovery: Tellius

Outsourcing Pharma

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

117
117
article thumbnail

National Wear Red Day

Tria Health Blog

February 4th is National Wear Red Day. This day focuses on increasing awareness for women’s heart health. While most heart disease and stroke deaths are preventable, cardiovascular diseases continue to be the greatest health risk for women.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Healthcare data breaches hit all-time high in 2021, impacting 45M people

Fierce Healthcare

Healthcare data breaches hit all-time high in 2021, impacting 45M people. hlandi. Tue, 02/01/2022 - 16:25.

141
141
article thumbnail

What does 2022 have in store for the telehealth sector?

pharmaphorum

Telehealth came to the fore in in 2020 and 2021 as healthcare systems struggled to deal with the consequences of the pandemic, but the coming year could see big changes to the sector after a period of breakneck growth. A new report from Boston Consulting Group’s Digital Ventures team predicts that with the category becoming increasingly crowded there will be consolidation as the early movers try to stay ahead of upstart competition – as already seen with 2020’s $18.5 billion merger b

More Trending

article thumbnail

Working in partnership to harness the potential of digital technology

NICE

Following the announcement last year of a two-year collaboration agreement between NICE and the AHSN Network , I wanted to consider the alignment between the two organisations and specific ways this agreement looks to further strengthen the use of the best evidence-based healthcare in the NHS. NICE and the AHSN Network share the common purpose of identifying and accelerating the uptake of well-evidenced innovations into health and care services to improve quality, safety, outcomes and experience

52
article thumbnail

Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave

Fierce Healthcare

Unvaccinated 23 times more likely than boosted to be hospitalized during omicron wave. dmuoio. Tue, 02/01/2022 - 16:13.

Hospitals 135
article thumbnail

Dr Reddy’s jumps on medical cannabis train, buying Nimbus Health

pharmaphorum

India’s Dr Reddy’s Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an undisclosed sum. While the regulatory framework for cannabinoid products remains fragmented and hard to navigate around the world, Germany has emerged as an early-mover.

article thumbnail

UK research hub launched to tackle rare kidney disease

Outsourcing Pharma

The Stoneygate and Kidney Research UK Alport Research Hub aims to accelerate research and develop treatments for Alport syndrome, a rare genetic disorder.

98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharmacy Bill: a Kaleidoscope

Pharma Tutor

Pharmacy Bill: a Kaleidoscope. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. . admin. Fri, 02/04/2022 - 14:11. Tags. Articles.

52
article thumbnail

Meditation app Calm buys Ripple Health Group to build out mental healthcare offerings

Fierce Healthcare

Meditation app Calm buys Ripple Health Group to build out mental healthcare offerings. rtorrence. Thu, 02/03/2022 - 15:04.

135
135
article thumbnail

New diagnostic finds hidden lung damage in long COVID

pharmaphorum

People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not show up using routine diagnostic scans, according to a small UK study. The researchers from Oxford, Sheffield, Cardiff and Manchester universities used a new form of diagnostic that involves patients breathing in the inert gas xenon whilst undergoing an MRI scan, which allows them to gauge how well gases like oxygen are being transferred from the lungs to blood vessels.

111
111
article thumbnail

Rare and orphan conditions take center stage during webinar

Outsourcing Pharma

During OSPâs exclusive February 23 webinar Rare and Orphan Diseases, leading expertswill lend their unique experience and expertise to the important topic.

90
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children

Pharma Mirror

Rockville, Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced its role as a Data Coordinating Center on a team whose work has accelerated pediatric COVID-19 research through the Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care (POP02).

52
article thumbnail

Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions

Fierce Healthcare

Kindbody hits unicorn status with Vios Fertility Institute acquisition, new leadership additions. rtorrence. Tue, 02/01/2022 - 17:13.

130
130
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

FDA 104
article thumbnail

Biogen promises increased diversity in Phase 4 Aduhelm trial

Outsourcing Pharma

Biogen releases further details on how its Phase 4 post-marketing confirmatory study for Alzheimerâs drug, Aduhelm, will run: including increased enrolment and enhanced efforts to encourage diversity.

84
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Why You Need Doctor’s Prescriptions for Antibiotics

Lifewell Rx Pharmacy

Antibiotics are medications that are given to someone with infection. It is used to destroy or slow down bacterial growth and prevent infections from getting any more complicated. Usually, any pharmacy carrying antibiotics would require you to show a doctor’s prescription before you can purchase them. It is a powerful medication but should be used with caution.

article thumbnail

Butterfly Network, Ambra Health team up to streamline medical imaging integration

Fierce Healthcare

Butterfly Network, Ambra Health team up to streamline medical imaging integration. agliadkovskaya. Thu, 02/03/2022 - 16:18.

124
124
article thumbnail

How does rare disease prevalence impact drug pricing in England?

pharmaphorum

In this second article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discusses the role that disease rarity plays in reimbursement decisions among payers in England, comparing assessments by NICE versus the NHS. Decision makers in the healthcare industry including payers, especially those who rely on the use of cost-effectiveness analysis (CEA) to evaluate new drugs, are often criticised for failing to capture the holistic value of drugs in their health te

103
103
article thumbnail

Memorial Sloan Kettering announces $100m gift for cancer research

Outsourcing Pharma

The oncology centerâs Marie-JosÃe and Henry R. Kravis Cancer Ecosystems Project is intended to elevate the next generation of preclinical cancer research.

79
article thumbnail

Longterm Benefits of Wearing Scrubs to Work

Pharma Mirror

Everybody knows that life as a caretaker can get rough sometimes, but it also comes with its fair share of benefits. In this article, we aim to highlight some of the long-term benefits of wearing scrubs to work, day in and day out. Being youthful at heart and work Depending on the scrub policy you have at your place of work, charcoal grey scrubs can add a completely new layer to your professional attire.

52
article thumbnail

Investment firm will take SOC Telemed private in deal valued at $300M

Fierce Healthcare

Investment firm will take SOC Telemed private in deal valued at $300M. hlandi. Fri, 02/04/2022 - 11:24.

122
122
article thumbnail

Novavax COVID jab ‘could save UK money on boosters’

pharmaphorum

The approval of Novavax’ COVID-19 vaccine in Great Britain could help the country save a “considerable amount of money” if it is used in future booster campaigns, according to the former chair of UK Vaccine Taskforce. Dr Clive Dix said that Nuvaxovid has excellent clinical data and – as a it has good stability at fridge temperatures – could be easily rolled out with the flu vaccine next winter, and should “replace the need to buy more Pfizer and Moderna vaccine.” Nu

article thumbnail

Altimmune obesity drug candidate lands IND clearance from the FDA

Outsourcing Pharma

The pharma firm has announced the agency has approved the companyâs investigational new drug application for its Phase II trial of pemvidutide for obesity.

FDA 70
article thumbnail

How is NICE supporting digital health technology developers?

NICE

From sensor-enabled glasses that facilitate self-management for major depression to devices that measure muscle performance to improve a person’s gait, NICE has worked in partnership with Innovate UK and the University of Manchester to support 16 digital health technology (DHT) developers over the last three years as part of the Digital Health Technology Catalyst.

article thumbnail

From Amazon to New Balance, consumer brand execs bring 'outsider' perspective to healthcare

Fierce Healthcare

From Amazon to New Balance, consumer brand execs bring 'outsider' perspective to healthcare. agliadkovskaya. Thu, 02/03/2022 - 15:26.

119
119
article thumbnail

No news anytime soon on Sandoz sale, says Novartis

pharmaphorum

Novartis chief executive Vas Narasimhan has downplayed any chances of swift decision on the future of its generics business Sandoz, saying that a decision on the possible sale of the unit may not come until the last quarter of the year. The comments came despite rumours of another private equity bid for Sandoz, with Bloomberg saying it had got wind of a $25 billion combined bid from investment groups Blackstone and Carlyle, with others including Advent International, Hellman & Friedman and K

98
article thumbnail

People on the Move: February 2022

Outsourcing Pharma

This monthâs announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

52
article thumbnail

Recipharm acquires GenIbet to bolster Biologics offering

Pharma Mirror

Global contract development and manufacturing organisation (CDMO), Recipharm, has today announced the acquisition of GenIbet, a Portuguese CDMO, specialising in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the Biologics market, with a particular focus on drug substance manufacturing of novel ATMPs.

52
article thumbnail

Warren calls for end to Direct Contracting, reforms to Medicare Advantage risk adjustment

Fierce Healthcare

Warren calls for end to Direct Contracting, reforms to Medicare Advantage risk adjustment. rking. Wed, 02/02/2022 - 16:57.

119
119
article thumbnail

Twelve simple ways to get ahead of acute stress

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at dealing with sudden stress and turning it into positive energy. We’ve all been there: stomach revolting, heart pounding, hands moist.